ETF Portfolio Partners, Inc. Sarepta Therapeutics, Inc. Transaction History

ETF Portfolio Partners, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$93.7 - $141.53 $167,348 - $252,772	1,786 New	1,786 $231,000
Q1 2023 Apr 25, 2023	BUY	$117.53 - $155.99 $28,207 - $37,437	240 Added 15.52%	1,786 $246,000
Q4 2022 Jan 10, 2023	BUY	$100.86 - $132.13 $155,929 - $204,272	1,546 New	1,546 $0
Q1 2021 Apr 15, 2021	SELL	$72.25 - $168.95 $312,698 - $731,215	-4,328 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$93.0 - $171.7 $110,949 - $204,838	1,193 Added 38.05%	4,328 $694,000
Q1 2020 Apr 13, 2020	BUY	$82.38 - $131.64 $41,190 - $65,820	500 Added 18.98%	3,135 $307,000
Q4 2019 Jan 13, 2020	BUY	$76.53 - $135.58 $201,656 - $357,253	2,635 New	2,635 $340,000
Q3 2019 Oct 21, 2019	SELL	$72.81 - $156.91 $191,854 - $413,457	-2,635 Closed	0 $0
Q2 2018 Jul 12, 2018	BUY	$71.74 - $153.69 $189,034 - $404,973	2,635 New	2,635 $348,000

525

84.4M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of ETF Portfolio Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on ETF Portfolio Partners, Inc. with notifications on news.